Rapid Infusion Rituximab for Maintenance Therapy: Is It Feasible?

Rituximab is an anti-CD-20 monoclonal antibody used in the management of lymphoproliferative disorders. The use of maintenance rituximab has improved progression free survival and overall survival in follicular lymphomas. Although rapid rituximab infusions have been studied extensively, there is lit...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Jolly, Ho, Melissa, Ho, Viet, Bello, Celeste, Djulbegovic, Benjamin, Sokol, Lubomir, Wetzstein, Gene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833187/
https://www.ncbi.nlm.nih.gov/pubmed/24288618
http://dx.doi.org/10.1155/2013/629283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833187/
https://www.ncbi.nlm.nih.gov/pubmed/24288618
http://dx.doi.org/10.1155/2013/629283

Ejemplares similares